Deputy Editors in Chief
The deputy editors in chief provide support to the editor in chief on editorial decision-making, and are responsible for editorial-decisions when the editor in chief is unavailable or has declared a conflict of interest.
Salvatore Lepore, PhD
Salvatore D. Lepore is an Associate Professor in the Department of Chemistry at Florida Atlantic University. Prior to his faculty appointment, Salvatore was a Postdoctoral Fellow at Eli Lilly under the direction of M.R. Wiley where he focused on the development of new solid-phase synthesis techniques with applications in anti-coagulation drug discovery. His doctorate was awarded in 1997 from Purdue University in the research group of M.B. Andrus.
At Purdue, he specialized in natural product total synthesis and structure/activity studies of multidrug resistance (MDR) inhibitors. His Bachelor's Degree in Chemical Engineering was earned at the University of South Florida in 1992. Salvatore currently oversees an active, NIH- and NSF-funded research group (click here for more info) that focuses primarily on organic chemistry as applied to drug discovery. His specific interests include the development of new leaving groups with molecular recognition properties; and synthesis methods involving allenyl carbonyl compounds.
Chris Liang, PhD
Chris Liang is currently the Director of Medicinal Chemistry of the Scripps Research Institute in Florida. His research focuses on the design of protein kinase inhibitors by combining the state-of-the-art computational modeling, combinatorial chemistry, and classic medicinal chemistry. He strives for the best and safest possible drugs by incorporating ADME, toxicity and other pharmaceutical considerations. Protein kinases are a class of enzymes that catalyze the transfer of the g-phosphate from ATP to protein substrates.
They play critical roles in signal transduction for a number of cellular functions. Protein kinase inhibitors have been shown to be useful in the treatment of many human diseases such as cancer, atherosclerosis, age-related macular degeneration, diabetic retinopathy, and inflammatory diseases. For examples, VEGFR inhibitors are particularly effective anti-angiogenesis agents, providing a novel non-cytotoxic mechanism for the treatment of cancer. Dr. Liang made significant contributions to the discovery of Sutent, a multi-targeted kinase inhibitor approved for stomach and kidney cancers. He also championed the discovery and development of U14813 currently in Phase II clinical trials.
Dr. Liang obtained his Ph.D. degree on chemistry from Princeton University in 1989. After a five-year tenure with Accelrys, he joined SUGEN, a biotech company pioneered research and drug discovery on protein kinases (SUGEN was acquired by Pharmacia which in turn was acquired by Pfizer). During his seven years at SUGEN, he made significant contributions to a number of drug discovery projects and was ultimately honored as Associate Fellow of the Pharmacia Corporation in 2003. He served as the Director of Chemistry until SUGEN was closed in 2003. Since 2004, Dr. Liang is the Director of Medicinal Chemistry at the Scripps Research Institute in Florida. He has over thirty scientific publications and over thirty patents in drug discovery.
The editorial board is the journal's primary source of peer reviewers and members occasionally provide assistance to the editor in chief. The editor in chief welcomes applications from suitable candidates to join the editorial board. Further information on the editorial board is available here.
J Aldrich-Wright, PhD
School of Science and Health, University of Western Sydney, Penrith, New South Wales, Australia
Helen E Blackwell, PhD
Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin, USA
Brian SJ Blagg, PhD
Professor of Medicinal Chemistry, Department of Medicinal Chemistry, The University of Kansas, Lawrence, Kansas, USA
Terry Bowlin, PhD
CEO, Microbiotix Inc, Worcester, Massachusetts, USA
Margaret A Brimble, PhD, CNZN, FRSNZ
Distinguished Professor, Chair of Organic and Medicinal Chemistry, The University of Auckland, Auckland, New Zealand
Daniel J Canney, PhD
Chair, Department of Pharmaceutical Sciences, Director of Graduate Studies, Assoc Professor of Medicinal Chemistry, Temple University, School of Pharmacy, Philadelphia, Pennsylvania, USA
William K Chan, PharmD, PhD
Professor, Department of Pharmaceutics and Medicinal Chemistry, Thomas J Long School of Pharmacy and Health Sciences, University of the Pacific, Stockton, California, USA
Geoffrey A Cordell, PhD
Emeritus Professor, University of Illinois at Chicago, and President, Natural Products Inc., Evanston, Illinois, USA
Kevin N. Dalby, PhD
Professor of Medicinal Chemistry, Southwestern Drug Corp. Centennial Fellow in Pharmacy, College of Pharmacy, The University of Texas at Austin, Austin, Texas, USA
Sunil A. David, PhD
Associate Professor, Department of Medicinal Chemistry, University of Kansas, Lawrence, Kansas, USA
Robert J Doerksen, PhD
Associate Professor, Department of Medicinal Chemistry, University of Mississippi, Oxford, Missouri, USA
Timothy Dore, PhD
Associate Professor of Chemistry, New York University Abu Dhabi, Abu Dhabi, United Arab Emirates
Chang-Deng Hu, PhD, MD
Associate Professor, Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy, Purdue University, West Lafayette, Indiana, USA
Longqin (Long) Hu, PhD
Professor of Medicinal Chemistry, Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA
Michael E. Johnson, PhD
Professor and Director, Center for Pharmaceutical Biotechnology, University of Illinois at Chicago, Chicago, Illinois, USA
Masato Koreeda, PhD
Associate Chair; Professor of Chemistry, University of Michigan, Ann Arbor, Michigan, USA
Michael A Kron, MD, MS
Department of Medicine, Biotechnology and Bioengineering Center, Medical College of Wisconsin, Milwaukee, Wisconsin, USA
Hung-wen Liu, PhD
George H Hutchings Regents Chair in Drug Design; Professor of Medicinal Chemistry, Chemistry and Biochemistry, Division of Medicinal Chemistry, College of Pharmacy, University of Texas, Austin, Texas, USA
Taifo Mahmud, PhD
Department of Pharmaceutical Sciences, Oregon State University, Corvallis, Oregon, USA
Alexander Mankin, PhD
Professor and Director, Center for Pharmaceutical Biotechnology, University of Illinois, Chicago, Illinois, USA
Christopher R. McCurdy, PhD, RPh
Associate Professor of Medicinal Chemistry and Pharmacology, Co-Director, NIH COBRE CORE-NPN, Department of Medicinal Chemistry, School of Pharmacy, University of Mississippi, MS, USA
Keykavous Parang, PharmD, PhD
Professor, Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Rhode Island, USA
Guido F Pauli, PhD
Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, Chicago, Illinois, USA
Daniel S Pilch, PhD
Associate Professor, Department of Pharmacology, UMDNJ-Robert Wood Johnston Medical School, Piscataway, New Jersey, USA
Bernard Pirotte, PhD
Professor, Department of Medicinal Chemistry, Drug Research Center, University of Liege, Liege, Belgium
Barry VL Potter, DPhil, DSc
Professor and Head of Medicinal Chemistry, Department of Pharmacy & Pharmacology, University of Bath, Bath, UK
Glenn D Prestwich, PhD
Presidential Professor, and Director, Center for Therapeutics Biomaterials, Department of Medicinal Chemistry, The University of Utah, Salt Lake City, Utah, USA
Daniel M Quinn, PhD
Professor of Chemistry, The University of Iowa, Iowa City, Iowa, USA
John M Rimoldi, PhD
Professor of Medicinal Chemistry, School of Pharmacy, University of Mississippi; Vice-President, Paradox Pharmaceuticals Inc.
Eduardo Sobarzo-Sánchez, PhD
Professor, Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Santiago de Compostela, Galicia, Spain
Ross L. Stein, PhD
Deputy Director, Institute for Advancing Medical Innovation, University of Kansas Medical Center, Kansas City, Kansas, USA
My experience publishing in Perspectives in Medicinal Chemistry was very positive. The submission process was very quick and easy. I was extremely impressed by the efficiency of the editorial staff and reviewers.